Spring Creek Capital’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Spring Creek Capital’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-300,000	Closed	-$11.3M	–	746
2021 Q1	$11.3M	Buy	+300,000	New	+$7.48M	0.49%	29

Spring Creek Capital's FPRX Position: Q2 2021 in Review

Spring Creek Capital sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 300,000 shares — an estimated $11.3M sold.

Spring Creek Capital first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $11.3M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Spring Creek Capital reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Spring Creek Capital sold 300,000 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $11.3M.
Spring Creek Capital first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Spring Creek Capital's Five Prime Therapeutics, Inc. position peaked at $11.3M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Spring Creek Capital's 13F filing for Q2 2021, filed 13 Aug 2021.